Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Influenza Vaccination After Acute Coronary Syndrome — Stella

Home/Acute Coronary Syndromes (ACS)/Influenza Vaccination After Acute Coronary Syndrome

View on ClinicalTrials.gov

Recruiting

Back to Acute Coronary Syndromes (ACS) trials

Influenza Vaccination After Acute Coronary Syndrome

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(1 site)

China

Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei

Key details

Sponsor

Tongji Hospital

Enrollment target

~6,620 participants

Started

December 2025

Primary completion

March 2029

Age range

18 Years – 80 Years

Last updated January 2026

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.